Literature DB >> 10537278

Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis.

V A Soldatenkov1, A Dritschilo, Z Ronai, S Y Fuchs.   

Abstract

Homologue of Slimb (HOS)/beta-transducin repeats containing proteins up-regulate nuclear factor kappaB activity by targeting its inhibitor (IkappaB) for ubiquitination and subsequent degradation. We investigated whether inhibition of HOS function may modulate apoptosis in human melanoma cells. Forced expression of the dominant negative HOSdeltaF construct inhibited IkappaB degradation and led to sensitization of melanoma cells to apoptosis induced by tumor necrosis factor alpha with cycloheximide, as well as by cisplatin and ionizing and UV irradiation. These data indicate that HOS plays an important role in controlling the IkappaB-dependent apoptotic pathways in human melanoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537278

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

2.  Vascular endothelial growth factor-induced elimination of the type 1 interferon receptor is required for efficient angiogenesis.

Authors:  Hui Zheng; Juan Qian; Christopher J Carbone; N Adrian Leu; Darren P Baker; Serge Y Fuchs
Journal:  Blood       Date:  2011-08-10       Impact factor: 22.113

3.  Role of β-TrCP ubiquitin ligase receptor in UVB mediated responses in skin.

Authors:  Neehar Bhatia; Tara A Demmer; Alok K Sharma; Irina Elcheva; Vladimir S Spiegelman
Journal:  Arch Biochem Biophys       Date:  2010-12-25       Impact factor: 4.013

4.  Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor.

Authors:  Hui Zheng; Juan Qian; Darren P Baker; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2011-08-24       Impact factor: 5.157

Review 5.  Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death.

Authors:  Domagoj Vucic; Vishva M Dixit; Ingrid E Wertz
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06-23       Impact factor: 94.444

6.  Spermatogenesis rescue in a mouse deficient for the ubiquitin ligase SCF{beta}-TrCP by single substrate depletion.

Authors:  Naama Kanarek; Elad Horwitz; Inbal Mayan; Michael Leshets; Gady Cojocaru; Matti Davis; Ben-Zion Tsuberi; Eli Pikarsky; Michele Pagano; Yinon Ben-Neriah
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

7.  Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells.

Authors:  K G Suresh Kumar; Jianghuai Liu; Ying Li; Duonan Yu; Andrei Thomas-Tikhonenko; Meenhard Herlyn; Serge Y Fuchs
Journal:  Cancer Biol Ther       Date:  2007-06-13       Impact factor: 4.742

8.  Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.

Authors:  Dongping Wei; Meredith A Morgan; Yi Sun
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

9.  beta-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor.

Authors:  Udi Gluschnaider; Guy Hidas; Gady Cojocaru; Vladimir Yutkin; Yinon Ben-Neriah; Eli Pikarsky
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

10.  Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses.

Authors:  S Bhattacharya; W-C HuangFu; G Dong; J Qian; D P Baker; J Karar; C Koumenis; J A Diehl; S Y Fuchs
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.